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Abstract
Objective: Implantation failure is an obstacle in assisted reproduction techniques (ART). Calcitonin is a molecules 
involved in uterine receptivity and embryo implantation. Melatonin can promote embryo quality and improve 
implantation. This study examines the effect of pretreatment of blastocysts with melatonin and calcitonin on heparin 
binding-epidermal growth factor (HB-EGF) expression in murine endometrium.
Materials and Methods: In this experimental study, we collected 2-cell embryos from the oviducts of 1.5 day pregnant 
NMRI mice. Embryos were cultured to the blastocyst in GTM medium with or without 10-9 M melatonin. Pregnant and 
pseudo-pregnant mice received intraperitoneal (IP) injections of 2 IU calcitonin. After 24 hours, we transferred the 
cultured blastocysts into the uteri of pseudo-pregnant mice. Two days later, implantation sites were counted and we 
assessed the levels of HB-EGF mRNA and protein in the uteri of naturally pregnant and pseudo-pregnant mice by 
quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot. Statistical analysis was performed with 
one-way ANOVA followed by the Tukey post hoc test. P<0.05 was considered statistically significant. 
Results: Melatonin pretreatment of blastocysts along with calcitonin administration significantly increased HB-EGF 
mRNA and protein (P<0.001) in the endometrium of pseudo-pregnant mice. Administration of calcitonin in naturally 
pregnant mice significantly increased HB-EGF mRNA and protein levels (P<0.001). Compared with the control group 
(2.6 ± 0.5), the average number of implantation sites in the melatonin group (4.6 ± 0.5, P<0.05) and calcitonin group (7 
± 1, P<0.001) significantly increased. There was a significant increase in implantation sites in the combined melatonin 
and calcitonin group (8.6 ± 0.5, P<0.001). Calcitonin significantly enhanced calcitonin receptor mRNA (P<0.001) and 
protein (P<0.05) in the uteri of naturally pregnant and pseudo-pregnant mice.                    
Conclusion: Melatonin pretreated blastocysts along with calcitonin increased HB-EGF expression in the uteri of pseudo-
pregnant mice. Calcitonin administration upregulated HB-EGF in uteri of naturally pregnant mice.
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Introduction
Infertility is one of the main problems amongst 
reproductive age couples. Approximately 12-16% of 
European and Asian couples suffer from infertility (1). 
Although the majority of these couples use assisted 
reproduction techniques (ART), the pregnancy rates 
remain low (2, 3). Unsuccessful embryo implantation 
is suggested to be the most important cause of this low 
pregnancy rate (4, 5). Less than 19% of transferred 
embryos can implant and develop to the delivery of a 
live neonate (6). Successful implantation and pregnancy 
occur by the simultaneous presence of a well-developed 
blastocyst and a receptive uterine endometrium. 
Alongside the deficiency of uterine receptivity, a low 
quality embryo may result in implantation failure in ART 
(7, 8). Despite the use of some medications to prevent 
implantation failure such as progesterone (9), leukemia 
inhibitory factor (LIF) (10), heparin, and aspirin, it has 
been reported that unfortunately these treatments do not 
have a valuable effect on uterine receptivity (10-12). 
Therefore, improving embryo quality and endometrial 
receptivity is a main concern in ART (13).
Embryo implantation is regulated by different types 
of growth factors, cytokines, and hormones (14, 15). 
Calcitonin is one of the factors that expresses in the uterine 
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epithelium during implantation (16). Suppression 
of calcitonin mRNA during the pre-implantation 
phase has been shown to considerably diminish the 
number of embryos in rats (17). Calcitonin supported 
trophoblastic outgrowth on human endometrial 
epithelial cells (EEC) (18). An indirect upregulation 
of heparin binding-epidermal growth factor (HB-EGF) 
has been reported after calcitonin administration (13). 
HB-EGF is a transmembrane protein expressed at the 
site of apposition in the endometrium and has a critical 
role in attachment and the invasion processes of 
implantation (19, 20). Initially, studies have reported 
that HB-EGF was a key factor of embryo implantation 
in mice and rats (21). Researchers have reported that 
HB-EGF expressed in human endometrium. Binding 
of HB-EGF to its receptors triggers signaling cascades 
which develop endometrial receptivity and are 
essential for implantation (20). It has been reported 
that HB-EGF triggers hatching of blastocysts from 
the zona pellucida (19). Thus, HB-EGF is a crucial 
molecule in implantation (22).
On the other hand, reactive oxygen species (ROS) 
is produced through the embryo culture (23) which 
causes cell damage, apoptosis, and alterations 
in gene expression (24). Melatonin (N-acetyl-5-
methoxytryptamine) is an effective free radical 
scavenger and antioxidant compared with vitamins 
C and E (23). Ishizuka et al. (25) have observed an 
increase in successful in vitro fertilization (IVF) after 
melatonin administration. Tian et al. (26) also reported 
a more developed and hatching blastocyst rate, as well 
as additional cell numbers in culture medium that 
contained 10-9 M melatonin. It is important to have a 
high quality embryo and increased uterine receptivity 
to improve implantation rates. We have designed this 
study to investigate the level of HB-EGF expression 
in the uteri of mouse pseudo-pregnant foster mothers 
following transfer of melatonin pretreated blastocysts 
in combination with calcitonin injection. 
 Materials and Methods
Animals and embryo collection
In this experimental study, we purchased 60 female 
NMRI mice (30-35 g), about 6 to 8-weeks old, from 
the Pharmacy Faculty of Tehran University of Medical 
Sciences (Tehran, Iran). All animal experiments were 
carried out according to the guidelines of the Iranian 
Council for Use and Care of Animals and approved 
by the Animal Research Ethical Committee of 
Tehran University of Medical Sciences (IR.TUMS.
REC.1395.2884). The mice were housed in an air-
conditioned room under a 12 hour light: 12 hour dark 
cycle (7 am: 7 pm) with free access to food and water 
(13). In this study, we used naturally pregnant and 
pseudo-pregnant mice that were divided into 9 groups-
three groups of naturally pregnant mice and 6 groups 
of pseudop-regnant mice. 
After two weeks of acclimation, female mice were 
superovulated by intraperitoneal (IP) injections of 5 
IU pregnant mare serum gonadotropin (PMSG, Sigma, 
USA) followed by an IP injection of 5 IU human 
chorionic gonadotropin (hCG, Karma, Germany) 48 
hours later (25). Then, the females were allowed to 
mate with fertile male NMRI mice overnight. The 
following day, the mice were examined for the presence 
of a vaginal plug; this date was designated as 0.5 days 
post coitum (dpc) (13). Mice with a vaginal plug were 
considered pregnant. We randomly divided these mice 
into 3 groups of 3 mice per group. At 2.5 dpc (27), 
the first group, pregnant mice+calcitonin (P+Cal) 
received 2 IU of calcitonin (Abcam, USA) (13). The 
second group, pregnant mice+normal saline (P+N.S) 
received normal saline. The third group, control or 
pregnant mice (P) received no treatment. 
Mice that had a positive vaginal plug were sacrificed 
by cervical dislocation 46-48 hours after the hCG 
injection to collect the embryos. The 2-cell stage 
embryos were mechanically flushed with Ham’s 
F10 medium (Merck Millipore, USA) supplemented 
with BSA (4 mg/ml) pre-warmed in an incubator at 
37˚C. Two-cell embryos were evaluated under a 
stereomicroscope (Nikon SMZ- 2T, Japan) and we 
randomly selected morphologically normal embryos 
(28) for further experiments. 
Embryo culture
A total of 10-15 normal embryos were cultured in 35-
50 μl microdrops of G-1TM (Vitrolife, Sweden) medium 
with or without 10-9 M melatonin (Sigma, USA) (26) 
under mineral oil (Sigma, USA) in a humidified 
incubator with 5% CO
2
 and 37˚C. The following day 
embryos were transferred to 35-50 μl microdrops of 
G-2TM (Vitrolife, Sweden) medium with or without 
10-9 M melatonin. We observed, 48 to 72 hours after 
initiation of culture, embryos at the early blastocyst, 
late blastocyst, and hatching blastocyst stages. Well-
developed blastocysts were randomly selected to 
transfer to the pseudo-pregnant foster mothers. 
Embryo transfer and in vivo tests
The 6 to 8-week-old virgin female NMRI mice 
were used as pseudo-pregnant foster mothers (or 
embryo recipients). For producing pseudo-pregnant 
mice as recipients or foster mothers, after induction 
of superovulation (as mentioned earlier) the mice 
were mated with vasectomized male mice of the same 
race (29). Mice that had a positive vaginal plug were 
randomly divided into 6 groups of 3 mice per group. The 
first and second groups consisted of pseudo-pregnant 
foster mothers that received transferred blastocyst 
cultured in G media as the control group (Pseudo-
P/G) or media supplemented with 10-9 M melatonin 
(Pseudo-P/M). The third and fourth groups consisted 
of pseudo-pregnant foster mothers who received an IP 
injection of normal saline and blastocysts cultured in G 
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media (Pseudo-P+N.S/G) or media supplemented with 
melatonin (Pseudo-P+N.S/M). In the fifth and sixth 
groups, pseudo-pregnant foster mothers received IP 
injections of 2 IU calcitonin 24 hours before embryo 
transfer and blastocysts cultured in G media (Pseudo-
P+Cal/G) or media supplemented with melatonin 
(Pseudo-P+Cal/M). Figure 1 summarizes the different 
groups.
Fig.1: Summary of the different experimental groups.
Under general anesthesia, we made a small hole on 
the left uterine horn a few millimeters further from the 
utero-tubal junction. Then, we used IVF Pasteur pipets 
(GmbH, Germany) to transfer 10 embryos per mouse 
(30) through the hole into the left uterine lumen of the 
recipients (31). After surgery the mice were allowed 
to recover in a clean cage with careful handling to 
prevent stressful conditions for the pregnant mice. The 
mice received intravenous administration of 0.1- 0.2 
ml Chicago sky blue dye (Santa Cruz, CA, USA, 1% 
in saline) 48 hours after embryo transfer (32). After 
30 minutes, the mice were killed. Blue bands in each 
uterus were considered to be the implantation sites, 
which we counted and compared them in the different 
groups.
Differential staining of blastocysts
We randomly chose expanded blastocysts for cell 
counting analysis. Blastocysts were removed from 
the culture media and placed in Ham’s F10 medium 
supplemented with 1% Triton X-100 and 100 μg/ml 
propidium iodide (PI, Sigma, USA) for approximately 
30-40 seconds. Then blastocysts were incubated 
in droplets that contained 25 μg/ml bisbenzimide 
(Hoechst, Sigma, USA), overnight at 4˚C in a dark 
chamber (29). The blastocysts were washed three times 
in phosphate-buffered saline (PBS) to remove residual 
dyes. Thereafter, embryos were mounted in a drop 
of glycerol on a microscope slide and covered by a 
coverslip. Samples were examined as soon as possible 
under fluorescent microscope (Olympus BX51TRF, 
Japan) equipped with a UV filter. The inner cell mass 
(ICM) nuclei were characterized with bisbenzamide 
(350-461 nm) and appeared blue, whereas the outer 
trophectoderm (TE) nuclei were recognized by the 
pink fluorescence of PI (535-617 nm). The ICM and 
TE cell numbers, and total cell numbers (TCN) were 
counted (33).
 RNA extraction and quantitative real-time polymerase
 chain reaction
Expression of HB-EGF and calcitonin receptor genes 
were assessed by quantitative real-time polymerase chain 
reaction (qRT-PCR) with TRIzol® reagent (Cinnagen, Iran). 
Total RNA was isolated from endometrial tissue, then mRNA 
(1 μg) was converted to cDNA via reverse transcription with 
an AccuPower® RocketScript™ RT PreMix kit (Bioneer 
Company). Specific primers along with cDNA and PCR 
reagents were placed into a real-time PCR machine 
(Applied Biosystems Step One, USA). The samples 
underwent an initial polymerase activation stage at 
95˚C for 15 minutes, followed by denaturation at 95˚C 
for 15 seconds, annealing at 60˚C for 20 seconds, and 
elongation at 72˚C for 20 seconds. Finally, we used the 
ΔΔCt technique for relative quantification of the data 
and further normalization to β-actin and fold change 
compared to the control.  The primers were designed with 
Gene Runner (version 3) and Primer Express (version 
3.05) software. The designed primers were blasted in 
http://www.ncbi.nlm.nih.gov/BLAST/. Table 1 lists the 
nucleotide sequences of the primers.
 Table 1: Primer Sequences for quantitative real-time polymerase chain
 reaction
Gene Primer sequencing (5ˊ-3ˊ) Product size 
(bp)
HB-EGF F: CCAGTTGCTACCCTGACTGG 
R: GAAGGGCTCACTCGATCCTG 
136
Calcitonin 
receptor
F: TAGTTAGTGCTCCTCGGGCT 
R: AGTACTCTCCTCGCCTTCGT 
116
β-actin F: CCACCATGTACCCAGGCATT 
R: AGGGTGTAAAACGCAGCTCA 
253
HB-EGF; Heparin binding-epidermal growth factor.
Western blot analysis
Western blot was performed to analyze HB-EGF and 
calcitonin receptor expressions at the protein levels. 
Defined proteins were acquired from frozen uterine 
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hoc tests and the independent-samples t test, using SPSS 16. 
P<0.05 was considered statistically significant.
Results
 Effect of blastocysts pretreated with melatonin on
 heparin binding-epidermal growth factor expression
We sought to explore the possible effects of melatonin on 
gene expression in the murine endometrium by transferring 
blastocysts pretreated with melatonin into the uteri of 
pseudopregnant foster mothers. QRT-PCR showed that 
blastocysts pretreated with 10-9 M melatonin induced and 
upregulated HB-EGF expression in the endometrium. The 
Pseudo-P/M, Pseudo-P+N.S/M, and Pseudo-P+Cal/M 
groups that received the melatonin pretreated blastocysts 
had significantly greater HB-EGF mRNA compared to 
the Pseudo-P/G (P<0.01), Pseudo-P+N.S/G (P<0.001), 
and Pseudo-P+Cal/G (P<0.001) groups (Fig.2). Western 
blot analysis confirmed the qRT-PCR results. There was a 
significant increase in HB-EGF protein in the Pseudo-P/M, 
Pseudo-P+N.S/M, and Pseudo-P+Cal/M groups compared 
to the Pseudo-P/G, Pseudo-P+N.S/G, and Pseudo-P+Cal/G 
groups (P<0.001, Fig.3A, B).
tissue by homogenization. Proteins were separated 
by 12% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). Proteins were fixed and 
stained by Kumasi blue dye to determine the protein 
position and concentration on blot and western set up. 
Then proteins transferred onto nitrocellulose membranes. 
The membranes were blocked in tris-buffered saline that 
contained 0.05% Tween-20 buffer (TBST) with 5% non-
fat milk, and then incubated with anti-HB-EGF (Santa 
Cruz, CA, USA), anti-calcitonin receptor, and anti-β-
actin antibody (Abcam, Germany, 1/100) overnight at 
4˚C followed by a one hour incubation with horseradish 
peroxidase (HRP) secondary antibody. Immunoreactive 
bands were envisioned by enhanced chemiluminescence. 
Finally, specific bands were quantified using Total Lab 
Quant analysis software (Total Lab Limited, UK). We 
analyzed the expression ratio of proteins to β-actin.
Statistical analysis
All experiments were performed in triplicate. The data are 
expressed as mean ± SD. To evaluate the statistical significance 
between different groups, we used one-way analysis of 
variance (ANOVA) followed by Tukey’s and Tamhane’s post 
Fig.2: Quantitative real-time polymerase chain reaction (QRT-PCR) analysis of HB-EGF and calcitonin receptor mRNA. A. The graph shows that the highest 
HB-EGF expression was observed in the Pseudo-P+Cal/M group. Also a significant higher expression was observed in the melatonin treated groups. In 
addition, calcitonin increased HB-EGF mRNA in endometrial tissues of naturally pregnant mice. Error bars represent means ± SD (n=3). *; P<0.001 vs. 
control and all experimental groups, **; P<0.01 vs. control and all experimental groups, #; P<0.001 vs. control and all experimental groups, except the 
Pseudo-P/M group, †; P<0.01 vs. control and all experimental groups except the Pseudo-P+N.S/M group and B. The graph shows that the mRNA level of 
calcitonin receptor in the calcitonin groups was higher than the other groups. *; P<0.001 vs. control and all experimental groups.
N.S; Normal Saline, Cal; Calcitonin, Pseudo-P; Pseudo-Pregnant, M; Media contain Melatonin, and G; GTM Media.
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Fig.3: Western blot analysis of HB-EGF and calcitonin receptor. A. Western 
blot bands of mentioned genes in different groups, B. As the graph shows, 
the Pseudo-P+Cal/M group had the highest expression of HB-EGF. The 
P+Cal and Pseudo-P+Cal/G groups had significantly higher expression. 
Data are shown as mean ± SD (n=3). *; P<0.001 vs. the control and all 
experimental groups, and C. Graph shows that Calcitonin receptor 
expression was higher in the calcitonin groups. **; P<0.01 vs. the control 
and all experimental groups, except the P+Cal and Pseudo-P+Cal/G 
groups. *; P<0.05 vs. the control and all experimental groups, except the 
Pseudo-P+Cal/M group.
N.S; Normal saline, Cal; Calcitonin, Pseudo-P; Pseudo-pregnant, M; Media 
contain melatonin, and G; GTM media.
 The effect of calcitonin and melatonin pretreated
 blastocysts on heparin binding-epidermal growth
 factor expression
The results show that transfer of melatonin pretreated 
blastocysts to the uteri of pseudo-pregnant mice that 
received a single dose of calcitonin had significantly 
upregulated mRNA expression of HB-EGF compared 
with the control and other experimental groups (P<0.001, 
Fig.2). At the protein level, Western blot analysis 
confirmed these results. A significant increase existed in 
HB-EGF protein levels in the Pseudo-P+Cal/M group 
(P<0.001, Fig.3A, B). In addition, our results showed that 
administration of calcitonin augmented mRNA levels of 
HB-EGF in endometrial tissues of naturally pregnant mice 
in the P-Cal group (P<0.001) and pseudo-pregnant foster 
mother mice following blastocyst transfer for the Pseudo-
P+Cal/G (P<0.01) and Pseudo-P+Cal/M (P<0.001) 
groups (Fig.2A). Western blot analysis confirmed the 
increased HB-EGF expression in the endometrial tissues 
of the P-Cal, Pseudo-P+Cal/G, and Pseudo-P+Cal/M 
groups. There was significantly greater HB-EGF protein 
in the endometria of the groups that received calcitonin 
compared to the other groups (P<0.001, Fig.3A, B).
 Calcitonin upregulates expression of the calcitonin
receptor in murine endometrium
Our data demonstrated that calcitonin receptor 
expression increased at the mRNA level in the P-Cal, 
Pseudo-P+Cal/G, and Pseudo-P+Cal/M groups (P<0.001, 
Fig.2B). Western blot results showed a significant increase 
in protein level of the calcitonin receptor in the P-Cal, 
Pseudo-P+Cal/G, and Pseudo-P+Cal/M groups treated 
with calcitonin (P<0.001, Fig.3A, C).
Differential blastocyst staining
We examined the effect of melatonin on embryo 
development by randomly staining the blastocysts with 
PI/Hoechst. The ICM, TE, and TCN were counted under 
a fluorescent microscope. As the results show, there was 
a significant increase in ICM, TE cell number, and TCN 
in melatonin pretreated groups compared with the control 
group (P<0.05, Fig.4).
Fig.4: Effects of melatonin on blastocyst cell numbers. Melatonin 
significantly increased the inner cell mass (ICM), trophectoderm (TE) cell 
number, and total cell number (TCN) compared to the control group. Data 
are shown as mean ± SD. (n=3). *; P<0.05 vs. control.
 Pretreatment of blastocysts with melatonin along with
 administration of calcitonin increased implantation of
blastocysts in vivo
According to the results, calcitonin enabled the 
endometrium to be more receptive for blastocysts to attach 
and implant. We checked the implantation sites 48 hours 
after the embryo transfer (Fig.5A). We observed that Pseudo-
P+Cal/M group had the highest number of implantation site 
(8.6 ± 0.5, Fig.5B). The melatonin pretreated groups (Pseudo-
P/M and Pseudo-P+Cal/M) had significantly more average 
number of implantation sites compared to the Pseudo-P/G 
A
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(P<0.001) and Pseudo-P+Cal/G (P<0.05) groups. Compared 
with the Pseudo-P/G group (2.6 ± 0.5), we observed an 
increased average number of implantation sites in the Pseudo-
P+Cal/G (7 ± 1) and Pseudo-P+Cal/M (8.3 ± 0.5) groups 
(both P<0.001, Fig.5B).
Fig.5: Effect of melatonin pretreated blastocysts along with administration 
of calcitonin on implantation of mouse blastocysts. The implantation sites 
were counted and compared in different groups. A. The arrows indicate 
implantation sites in the uterus and B. The average number of implantation 
sites. Data are shown as mean ± SD (n=3). *; P<0.05 vs. Pseudo-P+Cal/G 
and #; P<0.001 vs. Pseudo-p/G.
N.S; Normal saline, Cal; Calcitonin, Pseudo-P; Pseudo-pregnant, M; Media 
contain melatonin, and G; GTM media.
Discussion
ART procedures intend to overcome infertility and 
result in a greater pregnancy rate (13, 34). Although 
ART technique has been developed broadly, implantation 
failure is still one of the main obstacles for ART (13). HB-
EGF is one of the most important implantation genes in 
both humans and mice (22). Studies show that HB-EGF-/- 
female mice are sub-fertile (35). Previous studies have 
stated that active blastocysts are the main inducers of 
HB-EGF expression (21). Embryo quality may define the 
state of activity of a blastocyst (36). It has been suggested 
that the presence of an active blastocyst is needed to 
stimulate implantation (22). It is well known that different 
environmental factors such as an in vitro culture system 
and conditions, a high oxygen concentration (37, 38) and 
pH fluctuations (39) can produce more oxidative stress, 
which is harmful for early embryonic development (23, 
40, 41) and affect embryo quality and viability (42). 
They can also change embryo gene expression (37,43, 
44). Recently melatonin, a free radical scavenger and 
antioxidant, has been broadly used as a protective agent 
in the embryo culture (23, 45).
In the present study, we investigated the effect of 
melatonin pretreated blastocysts on HB-EGF expression 
in the uteri of pseudo-pregnant mice. Our results showed 
that pretreatment with melatonin increased expression 
of HB-EGF mRNA and protein after blastocyst transfer. 
Consistent with the current study findings, a recent study 
reported that pregnant mice injected with melatonin had 
increased HB-EGF expression in their endometrium and 
increased blastocyst activation in vivo (46). Morphological 
assessment of the blastocysts demonstrated that 10-9 M 
melatonin significantly enhanced TCN, ICM, and TE 
cells. Previous studies reported the same findings (26). As 
mentioned earlier, in addition to a high quality embryo, a 
receptive uterine is essential for successful implantation 
(47, 48). In recent years, various biological factors 
involved in endometrial receptivity have been identified 
(49). Among these, calcitonin is a well-known putative 
implantation gene (18) that plays a crucial role in uterine 
receptivity during implantation (34, 49, 50). In an in vitro 
EEC model, calcitonin has been shown to increase the 
outgrowth of trophoblasts on a human EEC monolayer 
(18). These results suggest that exogenous calcitonin 
may promote the competence of uterine receptivity and 
embryo implantation (13).
We investigated the effect of melatonin pretreated 
blastocyst and calcitonin administration on HB-EGF 
expression in uterine of pseudo-pregnant mice, as an 
in vivo model. Our data demonstrated that calcitonin 
administration significantly increased HB-EGF mRNA 
and protein in naturally pregnant mice and in pseudo-
pregnant mice after blastocyst transfer, which supported 
the results of a previous study where calcitonin indirectly 
up regulated HB-EGF mRNA expression in EECs (13). 
Transfer of melatonin pretreated blastocysts into pseudo-
pregnant mice that received calcitonin significantly 
increased HB-EGF mRNA and protein.
Taken together, these findings proposed that melatonin 
pretreated blastocysts along with administration of 
calcitonin could increase HB-EGF expression, a 
molecule associated with endometrial receptivity and 
embryo implantation. Consistent with previous reports, 
our results showed a significant increase in implantation 
rate in the melatonin (23) and calcitonin (13) groups. 
The implantation rate significantly increased in pseudo-
pregnant recipients that simultaneously received 
melatonin pretreated blastocysts and calcitonin. Calcitonin 
acts through binding to its cell surface receptor, a seven 
transmembrane G-protein-coupled receptor, to stimulate 
several signaling pathways that include the adenylyl 
cyclase and phospholipase C pathways. Adenylyl cyclase 
activation results in an increase in intracellular cyclic 
adenosine monophosphate (cAMP), which stimulates 
protein kinase A (PKA). In addition, inositol triphosphate 
is produced through phospholipase C activation which 
results in release of Ca2+ from intracellular stores (18).
Previous studies have reported that melatonin can 
promote blastocyst activation both in vivo and in vitro 
through changes in expression of some important embryo 
A
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development and implantation-related genes (37, 46). A 
number of these genes involved in Ca2+ signaling and 
the inositol 1, 4, 5-trisphosphate pathway significantly 
upregulates in activated blastocysts. Studies have 
revealed that blastocyst implantation can be regulated by 
Ca2+ signaling (51). Therefore, possibly melatonin and 
calcitonin can upregulate HB-EGF expression through a 
similar mechanism. 
Our results have demonstrated that calcitonin receptor 
significantly upregulated in murine endometrium after 
calcitonin administration. To our knowledge, there is little 
information about the effect of calcitonin on alteration 
of the calcitonin receptor in the uterus. Previous studies 
have reported that increased calcitonin receptor mRNA 
in blastocysts and calcitonin levels in the uterus occur 
simultaneously (52). Based on our data and reports from 
other studies, it can be suggested that calcitonin may 
induce calcitonin receptor expression in blastocysts and 
uteri. However, the current study results contrasted studies 
which have reported downregulation of the calcitonin 
receptor in osteoclasts after calcitonin administration (53). 
Additional research is required to explore the mechanism 
of an increased calcitonin receptor in endometrium via 
calcitonin administration. Given that HB-EGF is a crucial 
regulator of implantation (22), endometrial receptivity 
and embryo transfer programs may be promoted by 
pretreatment of blastocysts with melatonin and calcitonin 
administration. Additional research is required to prove 
the efficacy of blastocysts pretreated with melatonin 
and calcitonin in improving HB-EGF expression in 
endometrium and in embryo implantation during ART.
Conclusion
This study provided evidence that pretreatment of 
blastocysts with 10-9 M melatonin and administration of 
calcitonin to naturally pregnant and pseudo–pregnant 
mice could enhance HB-EGF expression, a critical 
molecule associated with endometrial receptivity and 
embryo implantation. Calcitonin might increase calcitonin 
receptor expression in murine endometrium.
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